| 0.6 |
1.9 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.3 |
1.1 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 |
0.8 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
0.5 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.1 |
0.4 |
GO:1905246 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.1 |
2.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.3 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 |
0.2 |
GO:0016539 |
intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
| 0.1 |
0.2 |
GO:2000523 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.1 |
0.3 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.1 |
0.4 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
0.6 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.1 |
0.4 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
0.4 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.3 |
GO:0003409 |
optic cup structural organization(GO:0003409) |
| 0.1 |
0.6 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
0.2 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.0 |
0.1 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.0 |
0.3 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.0 |
0.1 |
GO:0002514 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.0 |
0.3 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.4 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.2 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
| 0.0 |
3.5 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.0 |
0.1 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.5 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
0.5 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.0 |
0.5 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.0 |
0.2 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 |
0.2 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.0 |
0.1 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 |
0.2 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.0 |
0.5 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.1 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.0 |
0.0 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.5 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.1 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.0 |
0.3 |
GO:0031580 |
membrane raft polarization(GO:0001766) establishment of T cell polarity(GO:0001768) membrane raft distribution(GO:0031580) |
| 0.0 |
0.1 |
GO:0070446 |
cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.0 |
0.1 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.0 |
0.1 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.0 |
0.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.1 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 |
0.4 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.1 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 |
0.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
1.0 |
GO:0006882 |
cellular zinc ion homeostasis(GO:0006882) |
| 0.0 |
0.3 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 |
0.1 |
GO:2000646 |
lipid transport involved in lipid storage(GO:0010877) regulation of Cdc42 protein signal transduction(GO:0032489) positive regulation of receptor catabolic process(GO:2000646) |
| 0.0 |
0.0 |
GO:0003274 |
endocardial cushion fusion(GO:0003274) |
| 0.0 |
0.4 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.1 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.0 |
0.1 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.0 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.0 |
0.3 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.0 |
0.1 |
GO:0048861 |
oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.1 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.0 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.1 |
GO:0008050 |
female courtship behavior(GO:0008050) negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.0 |
0.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.1 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.1 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.2 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.3 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.2 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 |
0.4 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.1 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 |
0.2 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.0 |
0.1 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.3 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.0 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.0 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.0 |
0.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.0 |
0.0 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.0 |
0.2 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 |
0.0 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.0 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.1 |
GO:0001555 |
oocyte growth(GO:0001555) progesterone secretion(GO:0042701) |
| 0.0 |
0.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.1 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.0 |
0.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.0 |
0.0 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.0 |
0.3 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.1 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.0 |
0.8 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |